What does CUSIP G11217125 represent in this 13F holders report?

CUSIP G11217125 is the security identifier for BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 used to aggregate holder disclosures.

How many institutions held BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in Q4 2023?

No institutional holders were reported for BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in Q4 2023; review adjacent reporting periods for trend context.

202 (BIOSW)

CUSIP: G11217125

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / *W EXP 12/02/202
Total 13F shares: 0
Share change: -7,658,459
Total reported value: $0
Number of holders: 0
Value change: -$429,338
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2023

Recent filing periods for CUSIP G11217125:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW)

Q4 2023 13F Holders as of 31 Dec 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 as of Q4 2023.